Spadaro C, Arrigo-Reina R, Scoto G M
Pharmacol Res Commun. 1987 Mar;19(3):223-30. doi: 10.1016/0031-6989(87)90065-8.
The effects of morphine HCl and a synthetic met-enkephalin analogue [D-Ala2,MePhe4,Met(O)5ol]enkephalin (FK 33-824) on gastric damage produced by the intraperitoneal administration of indomethacin (10 mg/kg i.p.) have been investigated. Rats intraperitoneally pretreated with morphine HCl (10 mg/kg i.p.) and FK 33-824 (1 mg/kg i.p.) showed a statistically significant reduction both of the number and intensity of lesions induced by indomethacin. This protection was reversed by naloxone HCl (2 mg/kg i.p.). The protective effect was not related to a reduction of gastric secretion since the antisecretory drug cimetidine (25 mg/kg i.p.) and methscopolamine bromide (10 mg/kg i.p.) did not significantly prevent mucosal damage under the same experimental conditions.
研究了盐酸吗啡和一种合成的甲硫氨酸脑啡肽类似物[D-丙氨酸²,甲硫苯丙氨酸⁴,甲硫氨酸(氧代)⁵]脑啡肽(FK 33-824)对腹腔注射吲哚美辛(10毫克/千克腹腔注射)所致胃损伤的影响。预先腹腔注射盐酸吗啡(10毫克/千克腹腔注射)和FK 33-824(1毫克/千克腹腔注射)的大鼠,吲哚美辛诱导的损伤数量和强度均有统计学意义的显著降低。盐酸纳洛酮(2毫克/千克腹腔注射)可逆转这种保护作用。该保护作用与胃分泌减少无关,因为在相同实验条件下,抗分泌药物西咪替丁(25毫克/千克腹腔注射)和溴甲东莨菪碱(10毫克/千克腹腔注射)并不能显著预防黏膜损伤。